Completion of US-FDA Inspection at Sterile Product Division facility at Bengaluru

The company has announced that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Sterile Product Division facility (SPD) of OneSource Specialty Pharma Limited located at Opp. IIM, Bilekahalli, Bannerghatta Road, Bengaluru, 560076 from June 22, 2026 to June 30, 2026.

The inspection has concluded with one observation. The Company will respond to the observation comprehensively to FDA within the stipulated time frame.

Shares of Onesource Specialty Pharma Limited was last trading in BSE at Rs. 1668.70 as compared to the previous close of Rs. 1687.40. The total number of shares traded during the day was 6007 in over 691 trades.

The stock hit an intraday high of Rs. 1739.00 and intraday low of 1664.00. The net turnover during the day was Rs. 10221391.00.

Source : Equity Bulls

Keywords

OnesourceSpecialtyPharma INE013P01021 cGMP Inspection USFDA